996 studies found for:    Huntington's Disease
Show Display Options
Rank Status Study
21 Completed Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability
Condition: Huntington's Disease
Intervention: Drug: Creatine monohydrate
22 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: IONIS HTTRx;   Drug: Placebo
23 Not yet recruiting Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Cellavita HD lower dose;   Other: Cellavita HD intermediate dose;   Other: Cellavita HD Higher dose
24 Recruiting Exercise Effects in Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Exercise training
25 Completed Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
Condition: Huntington Disease
Interventions: Drug: (2)-epigallocatechin-3-gallate (EGCG);   Drug: Placebo
26 Recruiting Resveratrol and Huntington Disease
Condition: Huntington Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
27 Completed Effects of Lithium and Divalproex`on Brain-Derived Neurotrophic Factor in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: Lithium;   Drug: Divalproex
28 Completed Bioavailability of Ubiquinol in Huntington Disease
Condition: Huntington Disease
Intervention: Dietary Supplement: ubiquinol
29 Terminated Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Condition: Huntington's Disease
Interventions: Drug: Creatine Monohydrate;   Drug: Placebo
30 Completed Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease
Condition: Huntington's Disease
Intervention: Procedure: Stimulation
31 Recruiting Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride
Condition: Huntington Disease
Interventions: Drug: Olanzapine;   Drug: Xenazine;   Drug: Tiapridal
32 Not yet recruiting PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
Condition: Huntington's Disease
Intervention: Device: Deep Brain Stimulation
33 Completed
Has Results
Creatine Safety & Tolerability in Huntington's Disease
Condition: Huntington's Disease (HD)
Intervention: Drug: Creatine monohydrate
34 Recruiting REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)
Condition: Huntington Disease, Juvenile
Intervention:
35 Completed A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: ACR16;   Drug: Placebo
36 Completed A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ACR16 10 mg;   Drug: ACR16 22.5 mg;   Drug: ACR16 45 mg;   Other: Placebo
37 Unknown  Ursodiol in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ursodiol;   Drug: placebo
38 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
39 Completed Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
Condition: Huntington's Disease
Intervention: Drug: sodium phenylbutyrate
40 Completed Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Condition: Huntington's Disease
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years